Literature DB >> 34601826

Initial Formation of the Skin Layer of PLGA Microparticles.

Farrokh Sharifi1, Andrew Otte1, Kinam Park1,2.   

Abstract

Poly(lactide-co-glycolide) (PLGA) has been extensively used in making long-acting injectable formulations. The critical factors affecting the PLGA formulation properties have been adjusted to control the drug release kinetics and obtain desirable properties of PLGA-based drug delivery systems. The PLGA microparticle formation begins as soon as the drug/PLGA-dissolved in the organic solvent phase (oil phase) is exposed to the water phase. The initial skin (or shell) formation on the oil droplets occurs very quickly, sometimes in the matter of milliseconds, and studying the process has been difficult. The skin formation on the PLGA emulsion droplet surface that can affect the subsequent hardening steps is examined. PLGA droplets with different compositions are prepared. Using collimated light and a high-speed camera made it possible to detect the diffusion of acetonitrile from the oil phase into the water phase during the oil droplet formation. Although the skin formation is not visible on the surface of the oil phase droplet with the current setup, the droplet shapes, solid strand formation, and the difference in the spreading time suggest that the initial contact time between the oil and water phases in the range of a few seconds is critical to the properties of the skin.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  PLGA microparticles; droplet formation; precipitation; seed emulsion; skin formation; solvent diffusion

Mesh:

Substances:

Year:  2021        PMID: 34601826      PMCID: PMC8976859          DOI: 10.1002/adhm.202101427

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN: 2192-2640            Impact factor:   11.092


  44 in total

1.  Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method.

Authors:  Y Y Yang; H H Chia; T S Chung
Journal:  J Control Release       Date:  2000-10-03       Impact factor: 9.776

2.  A study of drug release from homogeneous PLGA microstructures.

Authors:  Ghanashyam Acharya; Crystal S Shin; Kumar Vedantham; Matthew McDermott; Thomas Rish; Keith Hansen; Yourong Fu; Kinam Park
Journal:  J Control Release       Date:  2010-04-08       Impact factor: 9.776

3.  The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.

Authors:  Andreas M Sophocleous; Kashappa-Goud H Desai; J Maxwell Mazzara; Ling Tong; Ji-Xin Cheng; Karl F Olsen; Steven P Schwendeman
Journal:  J Control Release       Date:  2013-09-08       Impact factor: 9.776

4.  A subtle end-group effect on macroscopic physical gelation of triblock copolymer aqueous solutions.

Authors:  Lin Yu; Huan Zhang; Jiandong Ding
Journal:  Angew Chem Int Ed Engl       Date:  2006-03-27       Impact factor: 15.336

5.  Effect of processing parameters on the properties of peptide-containing PLGA microspheres.

Authors:  R Jeyanthi; R C Mehta; B C Thanoo; P P DeLuca
Journal:  J Microencapsul       Date:  1997 Mar-Apr       Impact factor: 3.142

6.  Investigation on process parameters involved in preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens.

Authors:  X Li; X Deng; M Yuan; C Xiong; Z Huang; Y Zhang; W Jia
Journal:  Int J Pharm       Date:  1999-02-15       Impact factor: 5.875

Review 7.  Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery.

Authors:  Julien Nicolas; Simona Mura; Davide Brambilla; Nicolas Mackiewicz; Patrick Couvreur
Journal:  Chem Soc Rev       Date:  2013-02-07       Impact factor: 54.564

8.  In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering.

Authors:  Linbo Wu; Jiandong Ding
Journal:  Biomaterials       Date:  2004-12       Impact factor: 12.479

9.  Beyond Q1/Q2: The Impact of Manufacturing Conditions and Test Methods on Drug Release From PLGA-Based Microparticle Depot Formulations.

Authors:  John Garner; Sarah Skidmore; Haesun Park; Kinam Park; Stephanie Choi; Yan Wang
Journal:  J Pharm Sci       Date:  2017-10-26       Impact factor: 3.534

10.  Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.

Authors:  Farrokh Sharifi; Andrew Otte; Gwangheum Yoon; Kinam Park
Journal:  J Control Release       Date:  2020-07-07       Impact factor: 11.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.